INFORMATIVE: No Discretionary Denial Where Prior IPR Suggests Material Error By Office, PTAB Litigation Blog
Visit the PTAB Litigation Blog
The Acting Director ssued a decision declining to exercise discretionary denial in three related inter partes reviews (“IPRs”) filed by Padagis US LLC (“Padagis”): IPR2025-00464, IPR2025-00465, and IPR2025-00466 (collectively, “the Padagis IPRs”). These IPRs challenge U.S. Patent Nos. 8,895,546; 11,241,414; and 11,793,786, respectively, each of which is assigned to Neurelis, Inc. (“Neurelis”). On January 9, 2026, current USPTO Director John Squires designated the decision as informative.
Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.
